28 results
COVID-19 Diagnosis and Management Summary

 • Clinical Presentation
 • Testing
 • Imaging
 • Laboratory Findings
 •
COVID-19 Diagnosis ... and Management ... #COVID19 #diagnosis ... #management #treatment ... summary #sarscov2 #coronavirus
Running out of Analgesia and Sedation Medications due to #COVID19?  Anand Swaminathan, MD has put
due to #COVID19 ... #management ... #covid19 #treatment ... #criticalcare #coronavirus ... #medications #sedation
COVID-19 Infection - Clinical Presentation and Disease Progression for Severe Cases

Via https://doi.org/10.1007/s00134-020-05967-x

#COVID19 #Hospitalization #Disease #Progression #Severe
COVID-19 Infection ... Presentation and Disease ... 020-05967-x #COVID19 ... Progression #Severe #Coronavirus ... #Diagnosis #Management
Recent studies have revealed many attractive therapeutic options, even if some of them remain to be
clinical trials #covid19 ... #sarscov2 #management ... #treatment #coronavirus ... #medications
COVID-19: ICU Guidelines for the Non-Intensivist
Infection Control
Risk Factors for Severe Disease
Initial Laboratory Workup
COVID-19 Specific Medications
Respiratory
Cardiac
Hematologic
Neuro/Sedation

#COVID19 #ICU
COVID-19: ICU Guidelines ... Factors for Severe Disease ... -19 Specific Medications ... NonIntensivist #diagnosis ... #management
COVID-19 - A Seattle Intensivist's One-Page Cheat-Sheet on COVID-19 v2.7 Updated March 26 2020

(v2.7) incorporating newer
as data on new treatment ... Disease 2019 a.k.a ... emergency 2020-3-12 Diagnosis ... #Cheatsheet #Diagnosis ... #Management #Summary
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
of COVID-19 Infection ... Even with macular disease ... smfarmhosp_smfh #Drugs #Medications ... #Treatment #COVID19 ... Pharmacology #Table #Management
Gastroesophageal Reflux Disease (GERD) Summary
 - Diagnosis
 - Clinical Workflow
 - PPIs
 - Treatment
 - Acid
Gastroesophageal Reflux Disease ... GERD) Summary - Diagnosis ... Workflow - PPIs - Treatment ... Secretion and Medication ... #management
Bamlanivimab EUA - High Risk Criteria
 • BMI ≥ 35
 • Chronic kidney disease
 • Diabetes
Chronic kidney disease ... Immunosuppressive disease ... immunosuppressive treatment ... EUA #Criteria #covid19 ... #coronavirus #management
Shock - Differential Diagnosis Framework
 - MAP <65. SBP <90, drop in SBP > 40
 -
- Differential Diagnosis ... Failure, Toxins/Medications ... , Severe Valve Disease ... #Differential #Diagnosis ... #management